TITLE: The Genomic Actions and Functional Implications of Nuclear PRLr in Human Breast Carcinoma

[1]  M. Tkach,et al.  Progesterone Receptor Induces ErbB-2 Nuclear Translocation To Promote Breast Cancer Growth via a Novel Transcriptional Effect: ErbB-2 Function as a Coactivator of Stat3 , 2010, Molecular and Cellular Biology.

[2]  M. Hung,et al.  RNA helicase A is a DNA-binding partner for EGFR-mediated transcriptional activation in the nucleus , 2010, Proceedings of the National Academy of Sciences.

[3]  Traci Galbaugh,et al.  Cyclophilin B as a co-regulator of prolactin-induced gene expression and function in breast cancer cells. , 2010, Journal of molecular endocrinology.

[4]  F. Ali-Osman,et al.  Cyclooxygenase-2 Is a Novel Transcriptional Target of the Nuclear EGFR-STAT3 and EGFRvIII-STAT3 Signaling Axes , 2010, Molecular Cancer Research.

[5]  M. Bustin,et al.  The Nucleosome Binding Protein HMGN3 Modulates the Transcription Profile of Pancreatic β Cells and Affects Insulin Secretion , 2009, Molecular and Cellular Biology.

[6]  C. Clevenger,et al.  Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells. , 2009, Endocrinology.

[7]  H. Rui,et al.  Impaired turnover of prolactin receptor contributes to transformation of human breast cells. , 2009, Cancer research.

[8]  M. Waters,et al.  The extracellular domain of the growth hormone receptor interacts with coactivator activator to promote cell proliferation. , 2008, Molecular endocrinology.

[9]  W. Xia,et al.  Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression , 2008, Nucleic acids research.

[10]  John E Tomaszewski,et al.  Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma , 2008, Modern Pathology.

[11]  C. Clevenger,et al.  Quantification of PRL/Stat5 signaling with a novel pGL4-CISH reporter , 2008, BMC biotechnology.

[12]  U. Hansen,et al.  HMGN1 Modulates Estrogen-Mediated Transcriptional Activation through Interactions with Specific DNA-Binding Transcription Factors , 2007, Molecular and Cellular Biology.

[13]  M. Waters,et al.  Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis , 2007, Proceedings of the National Academy of Sciences.

[14]  Y. Shang,et al.  Regulation of SRC family coactivators by post-translational modifications. , 2007, Cellular signalling.

[15]  G. Carpenter,et al.  Role of the Sec61 translocon in EGF receptor trafficking to the nucleus and gene expression. , 2007, Molecular biology of the cell.

[16]  S. Gadd,et al.  Ligand-independent dimerization of the human prolactin receptor isoforms: functional implications. , 2006, Molecular endocrinology.

[17]  G. Bjursell,et al.  Nuclear Jak2 and Transcription Factor NF1-C2: a Novel Mechanism of Prolactin Signaling in Mammary Epithelial Cells , 2006, Molecular and Cellular Biology.

[18]  Richard A Young,et al.  Chromatin immunoprecipitation and microarray-based analysis of protein location , 2006, Nature Protocols.

[19]  J. Visvader,et al.  Socs2 and elf5 mediate prolactin-induced mammary gland development. , 2006, Molecular endocrinology.

[20]  M. Bustin,et al.  Distinct Domains in High Mobility Group N Variants Modulate Specific Chromatin Modifications* , 2006, Journal of Biological Chemistry.

[21]  S. Fuchs,et al.  Stabilization of prolactin receptor in breast cancer cells , 2006, Oncogene.

[22]  M. Hung,et al.  Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival , 2006, British Journal of Cancer.

[23]  J. Xie,et al.  Evaluation of genome-wide chromatin library of Stat5 binding sites in human breast cancer , 2005, Molecular Cancer.

[24]  M. Hung,et al.  Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. , 2005, Cancer research.

[25]  E. Lees,et al.  Chromatin acetylation and remodeling at the Cis promoter during STAT5-induced transcription. , 2003, Nucleic acids research.

[26]  C. Litterst,et al.  NCoA-1/SRC-1 Is an Essential Coactivator of STAT5 That Binds to the FDL Motif in the α-Helical Region of the STAT5 Transactivation Domain* , 2003, Journal of Biological Chemistry.

[27]  N. Navin,et al.  WW Domain-containing Protein YAP Associates with ErbB-4 and Acts as a Co-transcriptional Activator for the Carboxyl-terminal Fragment of ErbB-4 That Translocates to the Nucleus* , 2003, Journal of Biological Chemistry.

[28]  M. Waters,et al.  Suppressor of cytokine signalling gene expression is elevated in breast carcinoma , 2003, British Journal of Cancer.

[29]  S. Hankinson,et al.  The role of prolactin in mammary carcinoma. , 2003, Endocrine reviews.

[30]  L. Schuler,et al.  PRL activates the cyclin D1 promoter via the Jak2/Stat pathway. , 2002, Molecular endocrinology.

[31]  J. Harmon,et al.  Role of serine phosphorylation of Stat5a in prolactin-stimulated β-casein gene expression , 2001, Molecular and Cellular Endocrinology.

[32]  T. Golde,et al.  γ-Secretase Cleavage and Nuclear Localization of ErbB-4 Receptor Tyrosine Kinase , 2001, Science.

[33]  K. Makino,et al.  Nuclear localization of EGF receptor and its potential new role as a transcription factor , 2001, Nature Cell Biology.

[34]  T. Misteli,et al.  Mitotic Phosphorylation Prevents the Binding of HMGN Proteins to Chromatin , 2001, Molecular and Cellular Biology.

[35]  J. Manson,et al.  Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. , 1999, Journal of the National Cancer Institute.

[36]  G. Greene,et al.  Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells. , 1999, Molecular endocrinology.

[37]  M. Bustin,et al.  The chromatin unfolding domain of chromosomal protein HMG-14 targets the N-terminal tail of histone H3 in nucleosomes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Bustin,et al.  Clusters of nucleosomes containing chromosomal protein HMG-17 in chromatin. , 1997, Journal of molecular biology.

[39]  C. Powell,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Expression of Prolactin and Its Receptor in Human Breast Carcinoma* , 2022 .

[40]  J. Xu,et al.  Nuclear localization of a complex of fibroblast growth factor(FGF)-1 and an NH2-terminal fragment of FGF receptor isoforms R4 and R1alpha in human liver cells. , 1996, Biochimica et biophysica acta.

[41]  R. Coombes,et al.  Fibroblast Growth Factor Receptors (FGFRs) Localize in Different Cellular Compartments , 1995, The Journal of Biological Chemistry.

[42]  D. Buckley,et al.  The nuclear prolactin receptor: a 62-kDa chromatin-associated protein in rat Nb2 lymphoma cells. , 1995, Archives of Biochemistry and Biophysics.

[43]  A. Ullrich,et al.  Proline-rich Sequence-mediated Jak2 Association to the Prolactin Receptor Is Required but Not Sufficient for Signal Transduction (*) , 1995, The Journal of Biological Chemistry.

[44]  D. Buckley,et al.  Nuclear translocation of prolactin: Collaboration of tyrosine kinase and protein kinase C activation in rat Nb2 node lymphoma cells , 1995, Journal of cellular physiology.

[45]  I. Kerr,et al.  Jaks and Stats in signaling by the cytokine receptor superfamily. , 1995, Trends in genetics : TIG.

[46]  C. M. Chen,et al.  Nuclear translocation and anchorage of the growth hormone receptor. , 1994, The Journal of biological chemistry.

[47]  A. Ullrich,et al.  Prolactin-induced proliferation of Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2. , 1994, The Journal of biological chemistry.

[48]  W. Farrar,et al.  Activation of receptor-associated tyrosine kinase JAK2 by prolactin. , 1994, The Journal of biological chemistry.

[49]  M. Bustin,et al.  The footprint of chromosomal proteins HMG-14 and HMG-17 on chromatin subunits. , 1994, Journal of molecular biology.

[50]  M. Bustin,et al.  Nucleosome core binding region of chromosomal protein HMG-17 acts as an independent functional domain. , 1992, Journal of molecular biology.

[51]  P. Kelly,et al.  Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family , 1988, Cell.

[52]  D. Landsman,et al.  Chromosomal proteins HMG-14 and HMG-17. Distinct multigene families coding for similar types of transcripts. , 1986, The Journal of biological chemistry.

[53]  K. Bomsztyk,et al.  Protocol for the fast chromatin immunoprecipitation (ChIP) method , 2006, Nature Protocols.

[54]  R. Tjian,et al.  Transcriptional coactivator complexes. , 2001, Annual review of biochemistry.

[55]  P. Maher,et al.  Importin beta-mediated nuclear import of fibroblast growth factor receptor: role in cell proliferation. , 2001, The Journal of cell biology.

[56]  A. Wells,et al.  The nuclear accumulation of a variant epidermal growth factor receptor (EGFR) lacking the transmembrane domain requires coexpression of a full-length EGFR. , 2000, Molecular cell biology research communications : MCBRC.

[57]  M. Waters,et al.  Growth hormone receptor expression in the nucleus and cytoplasm of normal and neoplastic cells , 1998, Histochemistry and Cell Biology.